Expert Review of Non-Hodgkin's Lymphomas in a Population-Based Cancer Registry: Reliability of Diagnosis and Subtype Classifications

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 1, 2004, Pages 138-143

  Clarke, Christina A ^a   Glaser, Sally L ^a   Dorfman, Ronald F ^b   Bracci, Paige M ^c   Eberle, Erin ^a   Holly, Elizabeth A ^c  

^a NORTHERN CALIFORNIA CANCER CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; RELIABILITY; REVIEW;

ADULT; AGED; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; REPRODUCIBILITY OF RESULTS; SAN FRANCISCO; SEER PROGRAM;

EID: 1642446081     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-03-0250     Document Type: Review

References (28)

1. American Cancer Society. Cancer facts and figures. 2003. Atlanta, GA: American Cancer Society, 2003.
2. Ries, L. A. G., Eisner, M. P., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., Mariotto, A., Fay, M. K., Feuer, E. J., and Edwards, B. K. (eds.) SEER Cancer Statistics Review, 1973-2000. Bethesda, MD: National Cancer Institute, 2003.
3. Harris, N. L., Jaffe, E. S., Diehold J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., and Bloomfield, C. D. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, Novemher 1997. J. Clin. Oncol., 17: 3835-3849, 1999.
4. International Lymphoma Study Group. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood, 89: 3909-3918, 1997.
5. Groves, F. D., Linet, M. S., Travis, L. B., and Devesa, S. S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J. Natl. Cancer Inst. (Bethesda), 92: 1240-1251, 2000.
6. Eltom, M. A., Jemal, A., Mbulaiteye, S. M., Devesa, S. S., and Biggar, R. J. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J. Natl. Cancer Inst. (Bethesda), 94: 1204-1210, 2002.
7. National Cancer Institute Non-Hodgkin's Classification Project Writing Committee. Classification of non-Hodgkin's lymphomas. Reproducibility of major classification systems. Cancer (Phila.), 55: 91-95, 1985.
8. Dick, F., VanLier, S., Banks, P., Frizzera, G., Witrak, G., Gibson, R., Everett, G., Schuman. L., Isacson, P., O'Conor, G., et al. Use of the working formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnoses and a panel of experienced pathologists. J. Natl. Cancer Inst. (Bethesda), 78: 1137-1144, 1987.
9. Holly, E. A., Lele, C., and Bracci, P. Non-Hodgkin's lymphoma in homosexual men in the San Francisco Bay Area: occupational, chemical, and environmental exposures. J. Acquired Immune Defic. Syndr. Hum. Retrovirol., 15: 223-231, 1997.
10. Holly, E. A., and Lele, C. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: allergies, prior medication use, and sexual practices. J. Acquired Immune Defic. Syndr. Hum. Retrovirol., 15: 211-222, 1997.
11. Holly, E. A., Lele, C., and Bracci, P. M. Hair-color products and risk for non-Hodgkin's lymphoma: a population-based study in the San Francisco bay area. Am. J. Public Health, 88: 1767-1773, 1998.
12. Holly, E. A., Lele, C., Bracci, P. M., and McGrath, M. S. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am. J. Epidemiol., 150: 375-389, 1999.
13. Kamel, O. W., Holly, E. A., van de Rijn, M., Lele, C., and Sah. A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J. Rheumatol., 26: 1676-1680, 1999.
14. Tiirikainen, M. I., Mullaney B. P., Holly, E. A., Pallavicini, M. G., and Jensen, R. H. DNA copy number alterations in HIV-positive and HIV-negative patients with diffuse large-cell lymphomas. J. Acquired Immune Defic. Syndr., 27: 272-276, 2001.
15. Holly, E. A., Gautam, M., and Bracci, P. M. Comparison of interviewed and non-interviewed non-Hodgkin's lymphoma (NHL) patients in the San Francisco Bay Area. Ann. Epidemiol., 12: 419-425, 2002.
16. Chow, E. J., and Holly, E. A. Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study. Am. J. Epidemiol., 155: 725-731, 2002.
17. Holly, E. A., and Bracci, P. M. San Francisco population-based study of non-Hodgkin's lymphoma histology and medical history among HIV-negative participants. Am. J. Epidemiol., 158: 432, 2003.
18. Percy, C., Van Holten, V., and Muir, C. International Classification of Diseases for Oncology. Geneva: WHO. 1990.
19. Hennekens, C. H., and Buring, J. E. Epidemiology in Medicine. Boston: Little, Brown and Company, 1987.
20. Posner, K. L., Sampson, P. D., Caplan, R. A., Ward, R. J., and Cheney, F. W. Measuring interrater reliability among multiple raters: an example of methods for nominal data. Stat. Med., 9: 1103-1115, 1990.
21. Landis, J. R., and Koch, G. G. The measurement of observer agreement for categorical data. Biometrics, 33: 159-174, 1977.
22. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2000), released April 2003, based on the November 2002 submission. Silver Spring, MD: Information Management Services. Inc., 2003.
23. Glaser, S. L., Dorfman, R. F., and Clarke, C. A. Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry: interobserver reliability and impact on incidence and survival rates. Cancer (Phila.), 92: 218-224, 2001.
24. Zent, C. S., Kyasa, M. J., Evans, R., and Schichman, S. A. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer (Phila.), 92: 1325-1330, 2001.
25. Dick, F. R., VanLier, S. F., McKeen, K., Everett, G. D., and Blair, A. Nonconcurrence in abstracted diagnoses of non-Hodgkin's lymphoma. J. Natl. Cancer Inst. (Bethesda), 78: 675-678, 1987.
26. Greiner, T. C., Medeiros, L. J., and Jaffe, E. S. Non-Hodgkin's lymphoma. Cancer (Phila.), 75: 370-380, 1995.
27. Herrinton, L. J. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol. Rev., 20: 187-203, 1998.
28. Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., and Vardiman, J. Lymphoma classification-from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann. Oncol., 11 (Suppl. 1): 3-10, 2000.